Skip to main content English

Detail

Ulrike Resch
DI Dr. rer. nat. Ulrike Resch

Center for Physiology and Pharmacology (Institute of Vascular Biology and Thrombosis Research)
Position: Research Associate (Postdoc)

ORCID: 0000 0002 8380 9555
T +43 1 40160-31420/31428
ulrike.resch@meduniwien.ac.at

Keywords

Cell Communication; Endothelial Cells; Extracellular Fluid; Host-Pathogen Interactions; Inflammation; Innate Immunity; Oxidative Stress; Proteomics

Research group(s)

Research interests

One of my research focus is to understand cause and consequence of inflammation, which impacts health, life quality and longevity.

Central to me appears endothelial dysfunction, instigated by endogenous lipid and carbohydrate metabolic disorders (atherosclerosis, diabetes) and exogenous threats (bacterial- and viral infection, environmental poisons), altogether leading to inflammation, organelle dysfunction, oxidative stress and cell death.

Thus, it is important to understand mechanisms promoting the resolution of inflammation. In this context, free radical mediated damage of lipids and proteins, the generation of DAMPs and neoantigens (oxidation specific epitopes, OSE) link innate and adaptive immune responses. Therefore, mechanisms restoring a redox balance need to be investigated in more detail.


Another research focus is to investigate physico-chemical- and biochemical properties of extracellular vesicles (EVs).

These nano-sized, lipid-bilayered structures represent universal inter-and intracellular communication systems and their biological significance is becoming more and more evident. I am also interested in the interface prokaryotic-eukaryotic (inter-kingdom)-communication. From the prokaryotic side I focus on EVs released by the opportunistic Streptococcus pyogenes and the antibiotic-resistant Klebsiella pneumoniae and investigate their crosstalk with both professional and non-professional phagocytic cells (monocytes, endothelial cells).


I study the molecular composition of EVs to identify disease-signature proteins and to elucidate immunogenic structures presented by these EVs with the aim to develop cell- and tissue-specific biomarkers and new therapeutic treatment options.

Techniques, methods & infrastructure

Biochemistry (Signal Transduction, Protein expression, Posttranslational modifications, Enzymatic Assays, Immunoblotting, Immunohistochemistry, ELISA);

Preparative and analytical ultracentrifugation (Lipoproteins, Vesicles)

Molecular Biology (Cloning, RTq-PCR, gene silencing -shRNA-lentivirus, gene knock-out -CRISRP-Cas);

Proteomics (SILAC, Interaction/immuno-proteomics, phosphoproteomics, proteome profiling, clinical proteomics, 2D-DIGE)

Bioanalytics: MS (Orbitrap, TimsToF, MALDI), Chromatography (n/U-HPLC, DC, GC);

Omics-data analysis


Infrastructure:

Laboratories (BSL1, BSL2); Zellculture; Ultracentrifuges; Imager, Microscopes, FACS; Exoid; High performance Workstation